Abstract:Fifteen new polyprenylated acylphloroglucinols (1—15, PPAPs), along with 36 known PPAP derivatives were obtained from Hypericum kouytchense. Compound 1 was a rare PPAP with a fused 6/6/6/5/5 pentacyclic ring system. The primary mechanistic study of compound 34, implied that this compound could prohibit the function of P‐gp transport rather than its expression. Comprehensive Summary Given the lack of systematic polyprenylated acylphloroglucinols (PPAPs) research on traditional Chinese medicine of Hypericum kouytchense, this plant was applied for the phytochemical study, which led to fifteen new PPAPs (1—15, PPAPs), along with 36 known PPAP derivatives. Their structures and absolute configurations were established by comprehensive spectral analysis and theoretical ECD and NMR calculations. Structurally, compound 1 possesses a rare fused 6/6/6/5/5 pentacyclic ring system. Eleven compounds exhibited good multidrug resistance reversal activity (RF ranging from 5 to 53) in HepG2/ADR cells. Importantly, compound 34, the most potential MDR modulator, showed better reversal effect (RF: 53) than positive control, verapamil. The primary mechanistic study of compound 34, implied that this compound could prohibit the function of P‐gp transport rather than its expression. The possible recognition mechanism between compound 34 and P‐gp was predicted by molecular docking.

Seco-polyprenylated Acylphloroglucinols from Hypericum Elodeoides Induced Cell Cycle Arrest and Apoptosis in MCF-7 Cells Via Oxidative DNA Damage

Unprecedented Monoterpenoid Polyprenylated Acylphloroglucinols with a Rare 6/6/5/4 Tetracyclic Core, Enhanced MCF-7 Cells’ Sensitivity to Camptothecin by Inhibiting the DNA Damage Response

Kiiacylphnols A−H, eight undescribed polycyclic polyprenylated acylphloroglucinols with anticancer activities from Hypericum przewalskii Maxim

Unprecedented Nor-seco-polycyclic Polyprenylated Acylphloroglucinols Counteract Myocardial Cell Injury via Activation of the Akt/mTOR Signaling Pathway

Two rearranged acylphloroglucinols with moderate neuroprotective effects from Hypericum ascyron Linn.

Cytotoxic Polyprenylated Phloroglucinol Derivatives from Hypericum Elodeoides Choisy Modulating the Transactivation of RXRα.

Polyprenylated acylphloroglucinols as deubiquitinating protease USP7 inhibitors from Hypericum hookerianum

Polycyclic polyprenylated acylphloroglucinols from Hypericum beanii and their hepatoprotective activity

Hyperelodiones A-C, Monoterpenoid Polyprenylated Acylphoroglucinols from Hypericum Elodeoides, Induce Cancer Cells Apoptosis by Targeting RXRα.

Hyperkouytones A—O, New Polyprenylated Acylphloroglucinols from Hypericum kouytchense with Multidrug Resistance Reversal Activity

Polycyclic polyprenylated acylphloroglucinols (PPAPs) from Garcinia oblongifolia and their antitumoractivity.

Polycyclic polyprenylated acylphloroglucinol and phenolic metabolites from the aerial parts of Hypericum elatoides and their neuroprotective and anti-neuroinflammatory activities

Patumantanes A-D, seco -Polycyclic Polyprenylated Acylphloroglucinols with Diverse Carbon Skeletons from Hypericum patulum

Polycyclic polyprenylated acylphloroglucinols from the pericarps of Garcinia multiflora champ. ex Benth. with cytotoxic property

Polyprenylated acylphloroglucinols from Hypericum sampsonii with cytotoxicity against pancreatic carcinomas

Hyperbenzones A and B, two 1,2-seco and rearranged polycyclic polyprenylated acylphloroglucinols from Hypericum beanii

Discovery of 13,15-nor-polycyclic Polyprenylated Acylphloroglucinols from Hypericum Longistylum with Anti-Inflammatory Activity.

Diverse polycyclic polyprenylated acylphloroglucinols with anti-neuroinflammatory activity from Hypericum beanii

New polycyclic polyprenylated acylphloroglucinols with antidepressant activities from Hypericum perforatum L.

Discovery of Bioactive Polycyclic Polyprenylated Acylphloroglucinols from Hypericum Wilsonii.

Polycyclic Polyprenylated Acylphloroglucinol Congeners Possessing Diverse Structures from Hypericum Henryi